Shanghai, China

Guoquing Zhang

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guoquing Zhang: Innovator in Guanylate Cyclase C Agonists

Introduction

Guoquing Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biochemistry, particularly in the development of guanylate cyclase C agonists. With a total of two patents to his name, Zhang's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Zhang's latest patents include the "Process of preparing guanylate cyclase C agonists" and "Process of preparing guanylate cyclase C agonists." Both inventions provide processes for preparing peptides that include a GCC agonist sequence selected from a specific group of sequences described in the patents. These innovations highlight his expertise in peptide synthesis and its applications in medicine.

Career Highlights

Throughout his career, Guoquing Zhang has worked with reputable companies such as Bausch Health Ireland Limited and Synergy Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to important projects in the pharmaceutical industry.

Collaborations

Zhang has collaborated with notable colleagues, including Juncai Bai and Ruoping Zhang. These partnerships have likely facilitated the exchange of ideas and advancements in their respective fields.

Conclusion

Guoquing Zhang is a distinguished inventor whose work in guanylate cyclase C agonists showcases his innovative spirit and dedication to advancing medical science. His contributions are poised to make a lasting impact in the field of biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…